On May 21, 2025, MacroGenics, Inc. held its Annual Meeting of Stockholders, where 82% of shares participated, leading to the approval of four board candidates, the appointment of Ernst & Young as auditors, executive compensation, and an increase of 1.25 million shares for the 2023 Equity Incentive Plan.